⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2024Open Access

Supplementary Figure S4 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8⁺ T Cells via the HIF-1α–Glycolysis Pathway

Qiaoying Lv Tong Su Wei Liu Lulu Wang Jiali Hu Yali Cheng Chengcheng Ning Weiwei Shan Xuezhen Luo Xiaojun Chen

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure S4. ApoA1 mimetic peptide L-4F potentiates the antitumor effect of CD8⁺ T cells (related to Figure 4)

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lv et al. (2024) studied this question.

synapsesocial.com/papers/68e5e0e0b6db643587574dbf https://doi.org/10.1158/2326-6066.26423243.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S4 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8<sup>+</sup> T Cells via the HIF-1α–Glycolysis Pathway2024
2Supplementary Figure S3 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8<sup>+</sup> T Cells via the HIF-1α–Glycolysis Pathway2024
3Supplementary Figure S3 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8<sup>+</sup> T Cells via the HIF-1α–Glycolysis Pathway2024
4Supplementary Figure S5 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8<sup>+</sup> T Cells via the HIF-1α–Glycolysis Pathway2024
5Supplementary Figure S5 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8<sup>+</sup> T Cells via the HIF-1α–Glycolysis Pathway2024
6Supplementary Figure S2 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8<sup>+</sup> T Cells via the HIF-1α–Glycolysis Pathway2024
7Supplementary Figure S2 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8<sup>+</sup> T Cells via the HIF-1α–Glycolysis Pathway2024
8Supplementary Figure S6 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8<sup>+</sup> T Cells via the HIF-1α–Glycolysis Pathway2024